Package 63629-9174-2

{"route": ["ORAL"], "spl_id": "136ea151-859f-46ad-a6e5-b07f9ea968a2", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["bf1b4142-c5f3-4147-8224-bf6344566694"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET in 1 BOTTLE (63629-9174-1)", "package_ndc": "63629-9174-1", "marketing_end_date": "20261231", "marketing_start_date": "20220802"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (63629-9174-2)", "package_ndc": "63629-9174-2", "marketing_end_date": "20261231", "marketing_start_date": "20220802"}], "brand_name": "acyclovir", "product_id": "63629-9174_136ea151-859f-46ad-a6e5-b07f9ea968a2", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "63629-9174", "generic_name": "acyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA077309", "marketing_category": "ANDA", "marketing_end_date": "20261231", "marketing_start_date": "20060313"}